TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RVTY

Revvity Inc.

Healthcare · Diagnostics & Research

151.10$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RVTY
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12.6% 13.6% 16.6% 12.8% 11.2% 12.6% 23.6% 36.9% 20.5% 3.3% 22.8% 20.4%
4.9% 5.0% 4.7% 4.7% 6.5% 7.4% 6.5% 9.4% 12.9% 15.7% 15.5% 14.2%
0.6% 0.8% 0.8% 1.1% 1.0% 1.1% 0.8% 0.9% 1.6% 1.5% 1.4% 0.8%
– – – – – 2.9% 2.9% 0.5% -1.8% – – –
-2.7% -3.1% -1.7% -1.7% -4.7% -6.0% -3.1% 2.7% -11.5% -14.2% -0.7% -3.4%
1.3% 1.4% 1.5% 1.7% 3.4% 2.8% 2.0% 2.6% 2.6% 3.0% 3.1% 2.6%
-13.2% -4.8% -4.0% -56.1% -5.8% -16.9% -13.3% -107.4% -4.0% 47.8% 28.2% -0.6%
1.4% 1.5% 1.5% 1.4% 1.1% 1.1% 0.8% 0.8% 1.1% 1.3% 1.3% 1.1%
-2.9% -3.6% -7.2% -0.2% -2.1% -0.2% -0.2% -1.9% -2.4% -14.1% -13.4% -28.7%
– – – – – 7.2% -5.0% 80.3% -16.9% -18.8% -26.2% 0.0%
1.4% -5.1% -5.4% 34.7% -6.5% 5.2% -5.4% 76.8% -20.0% -34.4% -41.0% -29.9%
0.1% 3.0% 5.7% -7.0% -1.3% 0.9% 5.6% 5.7% -4.5% 16.1% 9.1% -8.6%
11.3% 12.2% 15.1% 11.0% 7.8% 9.8% 21.5% 34.2% 17.9% 0.4% 19.7% 17.8%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?